Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
about
The spatial resolution of epidemic peaksCost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic modelTrends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocolGeographic prioritization of distributing pandemic influenza vaccines.Modeling optimal age-specific vaccination strategies against pandemic influenza.A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.Joint modelling of serological and hospitalization data reveals that high levels of pre-existing immunity and school holidays shaped the influenza A pandemic of 2009 in the NetherlandsEarly vaccine availability represents an important public health advance for the control of pandemic influenza.Parental perceptions and predictors of consent for school-located influenza vaccination in urban elementary school children in the United StatesOptimal dosing and dynamic distribution of vaccines in an influenza pandemic.Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines.Mitigation of pandemic influenza: review of cost-effectiveness studies.Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA.Respiratory health issues in the Asia-Pacific region: an overview.Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great BritainOptimizing vaccine allocation at different points in time during an epidemic.Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everythingVaccine allocation in a declining epidemic.Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysisDynamic modeling for pandemic influenza.Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.Optimal vaccine allocation for the early mitigation of pandemic influenza.Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policyEconomics of influenza vaccine administration timing for children.Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty.Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada.Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study
P2860
Q27322738-D3DC68D5-04F3-41D0-86C3-1093819B1F53Q28748851-45CCEFE8-2BB6-46C3-8C33-E5ECDEF6732FQ30223026-55079F51-93BF-49A9-BAC5-E785381BFC80Q30224611-B348657E-7B7F-4A43-A9FE-59DF1D3EDE14Q30224852-1B7A6C60-D409-4E2A-BEB7-EF0001C6E17FQ30363098-8CF483D5-0F36-4F18-A1E5-F752C1E07F64Q30370138-E6928925-C5D7-4B89-88CA-A25902C9F672Q30374481-393C2DBF-AE0B-4597-8A16-07FE44CC5A9EQ30375649-CBA7AF3D-85D2-497A-890A-ABB66425C620Q30376523-852F3838-C4D7-4E00-88A8-B464A02DE772Q30379858-C31836EE-7226-4655-98B8-AED1FB9584F3Q30380700-2321548D-45B5-49FD-97BC-16A4BC23C1C8Q30382889-008E5241-8B50-4A11-91B0-E08F85BDE508Q30383318-4CDA3C5F-8452-4C44-9670-B7244BD9B580Q30385051-173D94F7-41E3-4358-8B33-A4392E338717Q30394490-7D75EA19-C448-44EB-8311-1BDDEB2C92C2Q30394832-4F3B1871-4836-4F95-B17F-1700BFCA71A4Q30396382-18F2F019-1523-43ED-B833-CE40679F3EFFQ30397016-6994883A-A775-4B68-AB74-9F0C4E237767Q30398939-44A2AD39-033D-4EB0-BB58-2F66350C7299Q30410632-E618FC16-F4ED-4CF1-AAB1-ED55075F762EQ30418929-EBFD0160-8C2A-49C7-97F2-B8CD44179958Q30419146-C7C9FF6D-8A6B-4832-85E8-510AA71A53A3Q30419587-4070C841-ABD3-424A-AACD-5DA2FB542B31Q30427045-13A7F6FA-FC96-4F92-9971-FABAF52E2636Q30428994-70D3CFF5-DC00-472C-82CB-EB0C6D69666EQ35048232-BBB64195-6C2A-4423-988F-80A0BCF46DDBQ37147657-54BDAB93-62E2-4513-9FE9-976EC9D24E0AQ37150722-BB54A8E8-3487-477D-BF7D-68F5663AA043Q52565452-9E800E2E-19FB-45BA-A30F-98C96C929854Q57110542-A42F7730-915E-47BC-8FEE-896269DBD04A
P2860
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@ast
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@en
type
label
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@ast
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@en
prefLabel
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@ast
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@en
P2093
P1433
P1476
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
@en
P2093
Anna K Lugnér
Sido D Mylius
Thomas J Hagenaars
P304
P356
10.1016/J.VACCINE.2008.04.043
P407
P577
2008-05-07T00:00:00Z